Magnetically modulated therapeutic systems
Section snippets
Principle of magnetic targeting
Magnetic drug delivery by particulate carriers is a very efficient method of delivering a drug to a localized disease site. Very high concentrations of chemotherapeutic or radiological agents can be achieved near the target site, such as a tumor, without any toxic effects to normal surrounding tissue or to the whole body. Fig. 1 highlights the concept of magnetic targeting by comparing systemic drug delivery with magnetic targeting. In magnetic targeting, a drug or therapeutic radioisotope is
History of magnetic targeting
Magnetic drug targeting is a young field. The surgeon Gilchrist published a seminal paper in 1956 on the selective inductive heating of lymph nodes after injection of 20–100-nm-sized maghemite particles into the lymph nodes near surgically removed cancer (Gilchrist et al., 1957). Turner and Rand combined then this radiofrequency heating method with embolization therapy (Turner et al., 1975).
Gilchrist apparently did not, however, envision that his magnetic particles could be magnetically guided
Magnetic delivery of chemotherapeutic drugs to liver tumors
The first clinical cancer therapy trial using magnetic microspheres (MMS) was performed by Lübbe et al. in Germany for the treatment of advanced solid cancer in 14 patients (Lubbe et al., 1996, Lubbe et al., 2001). Their MMS were small, about 100 nm in diameter, and filled with 4′-epidoxorubicin. The phase I study clearly showed the low toxicity of the method and the accumulation of the MMS in the target area. However, MRI measurements indicated that more than 50% of the MMS had ended up in the
Future directions
Conceptually, magnetic targeting is a very promising approach. However, there are a number of physical, magnetism-related properties which require careful attention. First, the magnetic force, which is defined by its field and field gradient, needs to be large and carefully shaped to fit the target area. For in vivo applications, this is not trivial, and collaborations with electrical or biomedical engineers are advisable. Second, the magnetic susceptibility of the MMS needs to be as high as
References (35)
- et al.
Synthesis of silicone magnetic fluid for use in eye surgery
J. Magn. Magn. Mater.
(1999) - et al.
Optimization of release from magnetically controlled polymeric drug release devices
Biomaterials
(1993) - et al.
Magnetically controlled targeted micro-carrier systems
Life Sci.
(1989) - et al.
Presentation of a new magnetic field therapy system for the treatment of human solid tumors with magnetic fluid hyperthermia
J. Magn. Magn. Mater.
(2001) - et al.
Control of release kinetics of macromolecules from polymers
J. Membr. Sci.
(1980) - et al.
Clinical applications of magnetic drug targeting
J. Surg. Res.
(2001) - et al.
Ferromagnetic silicone necrosis of hypernephromas by selective vascular occlusion to the tumor: a new technique
J. Urol.
(1975) - et al.
Magnetically responsive microspheres and other carriers for the biophysical targeting of antitumor agents
Adv. Pharmacol. Chemother.
(1979) - et al.
Selective targeting of magnetic albumin microspheres containing low-dose doxorubicin: total remission in Yoshida sarcoma-bearing rats
Eur. J. Cancer Clin. Oncol.
(1983) - et al.
Locoregional cancer treatment with magnetic drug targeting
Cancer Res.
(2000)
Synthesis and evaluation of colloidal magnetic iron oxides for the site-specific radiofrequency-induced hyperthermia of cancer
J. Magn. Magn. Mater.
Magnetically-responsive polymerized liposomes as potential oral delivery vehicles
Pharm. Res.
Therapeutic applications of immunomagnetic cell selection: a review
Eur. Cells Mater.
In vitro blockage of a simulated vascular system using magnetorheological fluids as a cancer therapy
Eur. Cells Mater.
Selective inductive heating of lymph nodes
Ann. Surg.
Magnetic targeted carriers offer site-specific drug delivery
Oncol. News Int.
Cited by (239)
Recent advances in drug delivery systems for glaucoma treatment
2022, Materials Today NanoCurcumin encapsulation in functional PLGA nanoparticles: A promising strategy for cancer therapies
2022, Advances in Colloid and Interface ScienceSynthesis of polypyrrole - Chitosan magnetic nanocomposite for the removal of carbamazepine from wastewater: Adsorption isotherm and kinetic study
2021, Journal of Environmental Chemical EngineeringCitation Excerpt :The surface modification can not only disperse magnetic particles in matrix and make better suspension stability but also provide an active surface for selective interaction with certain molecules in analytical applications. For example, a biologically active drug molecule and a ligand have been used as the functionalized outer coating for selective scavenging of metal ions [10,11]. The modifiers of the surface of MNPs are both inorganic and polymeric (organic) materials.
Polyelectrolyte multifaceted magnetic microcapsules for magnetic drug targeting at rheumatoid arthritic joints
2021, Handbook on Nanobiomaterials for Therapeutics and Diagnostic ApplicationsRole of targeted drug delivery in cancer therapeutics
2021, Advances and Challenges in Pharmaceutical Technology: Materials, Process Development and Drug Delivery Strategies